These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 916489)

  • 21. [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)].
    Yamamoto M; Morishita M; Hirano Y; Nagata A; Yazaki M
    Kekkaku; 1974 Jul; 49(7):195-9. PubMed ID: 4214961
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1980 Apr; 55(4):207-14. PubMed ID: 6993746
    [No Abstract]   [Full Text] [Related]  

  • 23. [A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
    Kameda K; Kino C
    Kekkaku; 1974 Nov; 49(11):387-91. PubMed ID: 4455991
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tuberactinomycin-N (enviomycin-EVM) in the treatment of pulmonary tuberculosis (author's transl)].
    Ishikawa H; Nakashima N; Okada H; Tsutsumi T; Ishizaki T; Oka R; Oda T; Shigeno Y; Yamaguchi K; Nakatomi M; Hara K
    Kekkaku; 1981 Jul; 56(7):369-74. PubMed ID: 6276611
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)].
    Urakami E; Nagasawa S
    Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical observation on capreomycin in the treatment of pulmonary tuberculosis (author's transl)].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):195-8. PubMed ID: 95505
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of multi resistant pulmonary tuberculosis with rifampin (author's transl)].
    Mena G; Carrasco E; Velasco J; Valenzuela P; Busel I
    Rev Med Chil; 1974 Oct; 102(10):798-803. PubMed ID: 4458021
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effects of tuberactinomycin-N (TUM-N) for severe pulmonary tuberculosis (author's transl)].
    Miwa T; Tsukamura M; Majima T; Ando Y; Kotetsu Y
    Kekkaku; 1975 Aug; 50(8):229-33. PubMed ID: 1195529
    [No Abstract]   [Full Text] [Related]  

  • 29. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The reactivation of pulmonary tuberculosis after effective chemotherapy using rifampicin].
    Roslik SM; Pashkov IuN; Matveeva SL; Gerasimova TG; Liudvichek IA; Iushchenko LP; Iakovleva LM; Stepanenko AL; Pankova LI
    Vrach Delo; 1990 Nov; (11):18-20. PubMed ID: 2098972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study on rifampicin applied every other day for severe cavitary pulmonary tuberculosis (author's transl)].
    Kitatani F; Fujimoto S; Asahi T; Konishiike J; Sera Y
    Kekkaku; 1974 May; 49(5):133-8. PubMed ID: 4408937
    [No Abstract]   [Full Text] [Related]  

  • 32. [Corticosteroids in the treatment of cavitating pulmonary tuberculosis (author's transl)].
    Saatçi H; Meral N
    Prax Klin Pneumol; 1980 Jan; 34(1):42-4. PubMed ID: 7367380
    [No Abstract]   [Full Text] [Related]  

  • 33. [Exudative pleurisy occurring during chemotherapy for pulmonary tuberculosis (author's transl)].
    Murakami T; Okumichi K; Kamada T; Mitani Y; Kutsukake F; Sasaki Y; Mochizuki K; Sato N
    Kekkaku; 1978 Jun; 53(6):331-8. PubMed ID: 691923
    [No Abstract]   [Full Text] [Related]  

  • 34. A follow-up study of 134 cases of pulmonary tuberculosis treated with adequate chemotherapy in 1953-1954.
    Cheung OT; Pugsley HE
    Can Med Assoc J; 1968 Jun; 98(25):1182-3. PubMed ID: 5657185
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adverse reactions of enviomycin during treatment for pulmonary tuberculosis (author's transl)].
    Miwa T; Tsukamura M; Kawase Y; Mashima T; Horie S; Seki F; Hashizume T; Hayashi S; Kondo I; Ariga F; Tanaka A; Takase K; Kawai M; Tanii Y; Matsutani I; Koketsu Y
    Kekkaku; 1980 Apr; 55(4):201-6. PubMed ID: 7392350
    [No Abstract]   [Full Text] [Related]  

  • 36. [Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
    Zhang LX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Dec; 4(6):349-51. PubMed ID: 7344873
    [No Abstract]   [Full Text] [Related]  

  • 37. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 38. [Follow-up studies of 100 pulmonary tuberculosis patients 5 years after their discharge from the hospital].
    Dieng M; Ayad M; Ruguizangoga E; Dia D; Wane S; Aidara K; Kane PA
    Dakar Med; 1981; 26(1):48-53. PubMed ID: 7238288
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and social characteristics of patients with pulmonary tuberculosis registered as follow-up group 2].
    Khudushina TA; Maslakova MG
    Probl Tuberk; 1997; (6):45-6. PubMed ID: 9503933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.